Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C22H17ClFN3O2S |
| Molecular Weight | 441.906 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)(O)C1=NC=C(C=C1)C2=C(OC(=N2)C3=CC=C(F)C=C3)SC4=NC=C(Cl)C=C4
InChI
InChIKey=DBZMCSVIITXLCC-UHFFFAOYSA-N
InChI=1S/C22H17ClFN3O2S/c1-22(2,28)17-9-5-14(11-25-17)19-21(30-18-10-6-15(23)12-26-18)29-20(27-19)13-3-7-16(24)8-4-13/h3-12,28H,1-2H3
Approval Year
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
77GX6MU9ZL
Created by
admin on Sat Dec 16 11:45:52 GMT 2023 , Edited by admin on Sat Dec 16 11:45:52 GMT 2023
|
PRIMARY | |||
|
1207745-58-1
Created by
admin on Sat Dec 16 11:45:52 GMT 2023 , Edited by admin on Sat Dec 16 11:45:52 GMT 2023
|
PRIMARY | |||
|
MK-4409
Created by
admin on Sat Dec 16 11:45:52 GMT 2023 , Edited by admin on Sat Dec 16 11:45:52 GMT 2023
|
PRIMARY | MK-4409 is a drug which acts as a potent and selective inhibitor of the enzyme fatty acid amide hydrolase (FAAH), with an IC50 of 11 nM, and both analgesic and antiinflammatory effects in animal studies. It was developed for the treatment of neuropathic pain and has progressed as far as early stage human clinical trials. | ||
|
DTXSID101045923
Created by
admin on Sat Dec 16 11:45:52 GMT 2023 , Edited by admin on Sat Dec 16 11:45:52 GMT 2023
|
PRIMARY | |||
|
53341130
Created by
admin on Sat Dec 16 11:45:52 GMT 2023 , Edited by admin on Sat Dec 16 11:45:52 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
